Sanda, Japan

Akira Fujishima

This inventor holds 14 USPTO granted patents and 1 EPO patent, primarily in Benzimidazole Compounds. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc.. Active years: 1998-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Fujishima. Retrieved from https://idiyas.com/inventor/akira-fujishima-h5vzqa7w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 35.7


Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 136(Granted Patents)


Location History:

  • Sanda, JP (1998 - 2009)
  • Hyogo, JP (2010 - 2015)

Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzimidazole
Compound
Crystal
Pharmaceutical
bFGF
Mutein
Production
Crystallization
Sanda
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Akira Fujishima

Introduction

Akira Fujishima is a prominent inventor hailing from Sanda, Japan. With a remarkable portfolio consisting of 14 patents, he has made significant advancements in the field of pharmaceutical compounds, particularly through his research and innovations.

Latest Patents

Among his latest contributions, Fujishima has developed novel benzimidazole compound crystals. These compounds, specifically designed as (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole or salts thereof, demonstrate utility as excellent antiulcer agents. The innovative nature of his work continues to pave the way for effective therapeutic solutions.

Career Highlights

Fujishima has an impressive background, having worked for notable companies such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His contributions during his tenure at these organizations have propelled advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Fujishima has collaborated with esteemed colleagues, including Isao Aoki and Keiji Kamiyama. These partnerships have played a crucial role in driving innovative research and enhancing the impact of his work in the industry.

Conclusion

Akira Fujishima's inventive spirit and dedication to advancing pharmaceuticals underscore his importance as an inventor. His ongoing contributions to the field reflect a commitment to improving health outcomes through innovative solutions and collaborative efforts. As he continues to develop groundbreaking compounds, Fujishima's legacy in the world of inventions remains significant.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…